Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cryolife (NY: CRY )

24.24 USD -0.58 (-2.34%)
Official Closing Price Updated: 7:00 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cryolife

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
CryoLife Announces Definitive Agreement to Acquire JOTEC
Provides Access into $2 Billion Global Stent Graft Market with Highly Competitive Technologically Advanced Product Portfolio 
From PR Newswire
Jeffrey H. Burbank Joins CryoLife Board of Directors
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced the appointment of Jeffrey H. Burbank to its Board of Directors... 
From PR Newswire
CryoLife to Present at Two Investor Conferences in September 2017
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that Pat Mackin, Chairman, President and Chief Executive... 
From PR Newswire
CryoLife to Present at 37th Annual Canaccord Genuity Growth Conference
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming 37th Annual Canaccord Genuity... 
From PR Newswire
CryoLife Reports Second Quarter 2017 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2017 Second Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 second quarter financial results will be released on Monday,... 
From PR Newswire
CryoLife to Present at Deutsche Bank 42nd Annual Health Care Conference
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming Deutsche Bank 42nd Annual Health... 
From PR Newswire
CryoLife Announces On-X Aortic Heart Valve PROACT Study Results to be Presented at American Association for Thoracic Surgery Centennial Meeting
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that results from the On-X aortic heart valve PROACT study will be... 
From PR Newswire
CryoLife Reports First Quarter 2017 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2017 First Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 first quarter financial results will be released on Wednesday,... 
From PR Newswire
CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results
Provides 2017 Financial Guidance 
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2016 Fourth Quarter and Year-End Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2016 fourth quarter and year-end financial results will be released... 
From PR Newswire
CryoLife to Present at Two Investor Conferences in November 2016
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that Pat Mackin, Chairman, President and Chief Executive Officer, will... 
From PR Newswire
CryoLife Reports Third Quarter 2016 Financial Results
Increases 2016 Financial Guidance 
From PR Newswire
James W. Bullock Joins CryoLife Board of Directors
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced the appointment of James W. Bullock to its Board of Directors effective... 
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2016 Third Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2016 third quarter financial results will be released on Wednesday,... 
From PR Newswire
CryoLife to Present at Ladenburg Thalmann 2016 Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming Ladenburg Thalmann 2016... 
From PR Newswire
CryoLife to Present at Morgan Stanley Global Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming Morgan Stanley Global Healthcare... 
From PR Newswire
CryoLife Appoints James McDermid as Chief Human Resources Officer
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today the appointment of James McDermid to the position of Chief Human Resources... 
From PR Newswire
CryoLife to Present at 2016 Wedbush PacGrow Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming 2016 Wedbush PacGrow Healthcare... 
From PR Newswire
CryoLife to Present at 36th Annual Canaccord Genuity Growth Conference
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming 36th Annual Canaccord Genuity... 
From PR Newswire
CryoLife Reports Second Quarter 2016 Financial Results
Increases 2016 Revenue and Earnings Guidance 
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2016 Second Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2016 second quarter financial results will be released on Monday,... 
From PR Newswire
CryoLife Reports First Quarter 2016 Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today its results for the first quarter of 2016. 
From PR Newswire
Over 70% of Americans Would Buy A Health Tracking Device if Clinically Accurate
From ACCESSWIRE
CryoLife Exercises Right to Acquire PhotoFix™ Bovine Pericardium Patch from Genesee BioMedical
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it has exercised its right to acquire the PhotoFix™ bovine... 
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2016 First Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2016 first quarter financial results will be released on Wednesday,... 
From PR Newswire
Biotricity (BTCY) Capitalizes on Healthcare IoT with Clear Pathway to Commercialization
From ACCESSWIRE
CryoLife Announces Sale of ProCol® Distribution Rights and Purchase Option to LeMaitre Vascular, Inc.
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that LeMaitre Vascular, Inc. (Nasdaq: LMAT) has acquired CryoLife's ProCol... 
From PR Newswire
CryoLife to Present at RBC Capital Markets Global Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming RBC Capital Markets Global... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.